Does Rallies show Form 4 insider transactions for QTTB?

Yes. Rallies tracks QTTB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is QTTB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for QTTB. It does not provide personalized investment advice.

QTTB (Q32 Bio Inc. Common Stock) Stock Analysis - Insider Trades

Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of May 21, 2026, QTTB trades at $5.61 with a market cap of $97.50M and a P/E ratio of 2.04. QTTB moved -6.43% today. Year to date, QTTB is +68.25%; over the trailing twelve months it is +220.34%. Its 52-week range spans $1.35 to $53.17. Analyst consensus is buy with an average price target of $14.33. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading QTTB stock inside the company?

Recent QTTB insider activity includes Kalowski Lee sold 4.00K, Morrison Jodie Pope sold 9.90K, Violette Shelia M. sold 2.81K, Morrison Jodie Pope sold 22.51K, and Kalowski Lee sold 9.07K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

QTTB Key Metrics

Key financial metrics for QTTB
Metric	Value
Price	$5.61
Market Cap	$97.50M
P/E Ratio	2.04
EPS	$2.79
Dividend Yield	0.00%
52-Week High	$53.17
52-Week Low	$1.35
Volume	122
Avg Volume	0
Revenue (TTM)	$53.92M
Net Income	$33.24M
Gross Margin	0.00%

Recent QTTB Insider Trades

Kalowski Lee sold 4.00K (~$18.04K) on Feb 25, 2026.
Morrison Jodie Pope sold 9.90K (~$44.67K) on Feb 25, 2026.
Violette Shelia M. sold 2.81K (~$12.71K) on Feb 25, 2026.
Morrison Jodie Pope sold 22.51K (~$77.87K) on Dec 2, 2025.
Kalowski Lee sold 9.07K (~$31.40K) on Dec 2, 2025.

Latest QTTB News

Q32 Bio Raises $10.5M, Holds $50.8M Cash and Doses First Open-Label Extension Patient — May 5, 2026
Q32 Bio to Present at Needham Conference April 15; Webcast Available for 90 Days — Apr 8, 2026
Q32 Bio Raises $10.5M, Extends Cash Runway to Q4 2027 — Mar 10, 2026
Q32 Bio sells asset for $12M plus up to $592M, eyes mid-2026 bempikibart data — Mar 1, 2026
Q32 Bio Secures $10.5M Financing with 1.67M Shares and 1.03M Warrants — Feb 17, 2026

QTTB Analyst Consensus

3 analysts cover QTTB: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.33.

Common questions about QTTB

Who is trading QTTB stock inside the company?: Recent QTTB insider activity includes Kalowski Lee sold 4.00K, Morrison Jodie Pope sold 9.90K, Violette Shelia M. sold 2.81K, Morrison Jodie Pope sold 22.51K, and Kalowski Lee sold 9.07K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for QTTB?: Yes. Rallies tracks QTTB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is QTTB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for QTTB. It does not provide personalized investment advice.